Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)

Show other versions (1)

Literature review of anemia pathogenesis in patients with lymphatic system malignancies is presented. Advantages and disadvanta ges of eritropoiesis-stimulating preparations (ESP) used for anemia correction are shown. Efficacy of anemia treatment with ESP in various types of lymphoproliferative diso...

Full description

Bibliographic Details
Main Authors: N. A. Romanenko, K. M. Abdulkadyrov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
anemic syndrome
non hodgkin’s lymphomas
lymphoproliferative disorders
multiple myeloma
anemia treatment
erythropoietin
erythropoiesis-stimulating agents
cytokine
chemotherapy
red blood cell transfusion
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/89
Description
Summary:Literature review of anemia pathogenesis in patients with lymphatic system malignancies is presented. Advantages and disadvanta ges of eritropoiesis-stimulating preparations (ESP) used for anemia correction are shown. Efficacy of anemia treatment with ESP in various types of lymphoproliferative disorders (LPD) is presented. Prognostic factors that predict positive response on ESP in LPD pati ents and reduce treatment cost are identified.
ISSN:1818-8346
2413-4023

Similar Items